Edition:
United States

Vexim SA (ALVXM.PA)

ALVXM.PA on Paris Stock Exchange

20.01EUR
11:35am EST
Change (% chg)

€-0.08 (-0.40%)
Prev Close
€20.09
Open
€20.10
Day's High
€20.10
Day's Low
€19.54
Volume
18,464
Avg. Vol
41,292
52-wk High
€20.15
52-wk Low
€9.06

Chart for

About

Vexim SA is a France-based company engaged in the medical sector. It develops invasive medical instruments used in preventing and treating vertebral fractures. The Company markets its flagship product, SpineJack, in Germany, the United Kingdom, Austria and Ireland under a agreement with Stryker Corp, in France via its own sales... (more)

Overall

Beta: 0.64
Market Cap(Mil.): €163.21
Shares Outstanding(Mil.): 8.12
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 57.04 15.47
EPS (TTM): -- -- --
ROI: -- 13.33 33.71
ROE: -- 19.92 16.38

BRIEF-Stryker to acquire Vexim

* Stryker Corp - ‍Stryker paid EUR 20.00 per share and EUR 3.91 per BSAAR warrant for deal​

Oct 24 2017

BRIEF-Vexim H1 net operating loss narrows to 1.5 million euros

* VEXIM: STRONG FIRST HALF 2017 RESULTS, IN LINE WITH EXPECTATIONS

Sep 14 2017

BRIEF-Vexim Q2 sales rise to 5.7 million euros

* ANTICIPATES A CONTINUED STRONG GROWTH IN SALES IN SECOND PART OF 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jul 11 2017

Earnings vs. Estimates